AbbVie seeks OK for new hepatitis C drug

SHARE AbbVie seeks OK for new hepatitis C drug

AbbVie Inc. has applied for U.S. approval of a new treatment for hepatitis C.

The North Chicago-based drugmaker said Tuesday testing of the new drug involved more than 2,300 patients in 25 countries. AbbVie expects to seek approval in the European Union in May.

“This (New Drug Application) submission is a significant advancement for AbbVie’s HCV development program,” said Dr. Scott Brun, the company’s vice president of pharmaceutical development. “We believe our all-oral, interferon-free regimen holds the potential to be a promising new therapy for patients living with this chronic infection.”

The company says about 3.2 million people in the U.S. live with the hepatitis C virus.

AbbVie to move 2,000 employees off North Chicago campus

Drugmaker AbbVie to set up plant in Singapore

AbbVie earnings hurt by generic drugs

The Latest
An 18-year-old man was shot and hospitalized in critical condition about 5:30 p.m. Tuesday in the 4800 block of South Marshfield Avenue . A 40-year-old man was taken into custody after a 40-minute standoff.
Despite trailing for much of the game, the Roadrunners’ trip to Florida for the Tampa Bay Christmas Invite prepared them for these close games.
Definition Theatre and Timeline Theatre Company were each awarded $180,000; Chicago Children’s Theatre received $100,000 and Remy Bumppo Theatre Company $50,000.
In a letter to City Council Black Caucus Chair Stephanie Coleman, Ald. Desmon Yancy alleged that he was the ‘victim of an unprovoked assault’ by Mitchell after a council hearing last week. Mitchell denies the claim, and police called the situation a “non-criminal incident.”
The workers, whom the company calls “partners,” say they are organizing for better working conditions and more reliable scheduling.